Ausgabe 1/2024
Special Issue: Metabolic Reprogramming in Cardiovascular Diseases
Inhalt (22 Artikel)
Urinary Marker Profiles in Heart Failure with Reduced Versus Preserved Ejection Fraction
Koen W. Streng, Hans L. Hillege, Jozine M. ter Maaten, Dirk J. van Veldhuisen, Kenneth Dickstein, Nilesh J. Samani, Leong L. Ng, Marco Metra, Gerasimos S. Filippatos, Piotr Ponikowski, Faiez Zannad, Stefan D. Anker, Peter van der Meer, Chim C. Lang, Adriaan A. Voors, Kevin Damman
Enhanced Levels of Adiposity, Stretch and Fibrosis Markers in Patients with Coexistent Heart Failure and Atrial Fibrillation
Xiaoran Fu, Diego Iglesias-Álvarez, Ana García-Campos, María Amparo Martínez-Monzonís, Cristina Almenglo, José Manuel Martinez-Cereijo, Laura Reija, Ángel Luis Fernandez, Jose Ramón Gonzalez-Juanatey, Moises Rodriguez-Manero, Sonia Eiras
The Fragmented QRS Complex in Lead V1: Time for an Update of the Athlete’s ECG?
Marco Vecchiato, Giulia Quinto, Nicola Borasio, Stefano Palermi, Giampaolo Berton, Francesca Battista, Andrea Gasperetti, Andrea Ermolao, Daniel Neunhaeuserer
Advances in Metabolic Remodeling and Intervention Strategies in Heart Failure
Simin Meng, Yi Yu, Shuo Yu, Shiyu Zhu, Mengjia Shi, Meixiang Xiang, Hong Ma
From Energy Metabolic Change to Precision Therapy: a Holistic View of Energy Metabolism in Heart Failure
Jianpei Wen, Chen Chen
Cardiac Metabolism, Reprogramming, and Diseases
Haichang Wang, Min Shen, Xiaofei Shu, Baolin Guo, Tengfei Jia, Jiaxu Feng, Zuocheng Lu, Yanyan Chen, Jie Lin, Yue Liu, Jiye Zhang, Xuan Zhang, Dongdong Sun
The Role of Branched-chain Amino Acids and Their Metabolism in Cardiovascular Diseases
Zhiyu Li, Yibin Wang, Haipeng Sun
Metabolomics Profiling Predicts Ventricular Arrhythmia in Patients with an Implantable Cardioverter Defibrillator
Shengwen Yang, Junhan Zhao, Xi Liu, Jing Wang, Min Gu, Chi Cai, Hongxia Niu, Liang Chen, Wei Hua
FAM3A Deficiency − Induced Mitochondrial Dysfunction Underlies Post-Infarct Mortality and Heart Failure
Tan Xu, Jiaxing Wang, Xiaoxiao Liu, Rui Xiang, Houhua Li, Shiqiang Wang, Jichun Yang, Ming Xu
Myocardial Metabolic Reprogramming in HFpEF
Zihui Zhang, Mingchu Sun, Wenhua Jiang, Lu Yu, Chan Zhang, Heng Ma
Diabetes Mellitus to Accelerated Atherosclerosis: Shared Cellular and Molecular Mechanisms in Glucose and Lipid Metabolism
Nan Zhao, Xiaoting Yu, Xinxin Zhu, Yanting Song, Fei Gao, Baoqi Yu, Aijuan Qu
The Characteristics of Macrophage Heterogeneity in Atherosclerotic Aortas
Yu-Jie Song, Yu Ma, Ting Meng, Tao Zhuang, Cheng-Chao Ruan, Yan Li, Guan-Nan Zhang
ALDH2: Essential Mediator for the Remote Ischemic Conditioning Strategy to Reduce Myocardial Ischemia/Reperfusion Injury
Yujiao Zhu, Zheng Jiao, Yihua Bei
Remote Ischemic Conditioning Mediates Cardio-protection After Myocardial Ischemia/Reperfusion Injury by Reducing 4-HNE Levels and Regulating Autophagy via the ALDH2/SIRT3/HIF1α Signaling Pathway
Rifeng Gao, Chunyu Lv, Yanan Qu, Hen Yang, Chuangze Hao, Xiaolei Sun, Xiaosheng Hu, Yiqing Yang, Yanhua Tang
Ferrostatin-1 Blunts Right Ventricular Hypertrophy and Dysfunction in Pulmonary Arterial Hypertension by Suppressing the HMOX1/GSH Signaling
Jiawei Song, Yihang Chen, Yufei Chen, Siyuan Wang, Zhaojie Dong, Xinming Liu, Xueting Li, Zhenzhou Zhang, Lanlan Sun, Jiuchang Zhong
Functions, Mechanisms, and therapeutic applications of the inositol pyrophosphates 5PP-InsP5 and InsP8 in mammalian cells
Ji Qi, Linhui Shi, Limei Zhu, Yuanyuan Chen, Hong Zhu, Weiwei Cheng, Alex F. Chen, Chenglai Fu
The Role of CCTA-derived Cardiac Structure and Function Analysis in the Prediction of Readmission in Nonischemic Heart Failure
Chengjia Liu, Shuangxiang Lin, Yangyang Sheng, Xinghong Wang, Jianzhong Sun, Jiaxing Wu, Risheng Yu
SGLT2 Inhibitors as the Backbone of Therapy for Cardiovascular and Renal Protection
Felice Gragnano, Fabrizia Terracciano, Paolo Calabrò
HIPK1: a New Druggable Kinase Target for Treating Pathological Cardiac Hypertrophy
Michail Spanos, Priyanka Gokulnath, Emeli Chatterjee, Dimitrios Varrias, Lingfei Sun, Saumya Das, Guoping Li